Which is stronger, oxycodone (OxyCodone HydroChloride) 10mg every 4 hours or OxyContin (Oxycodone) ER 12 hour 15mg every 4 hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

OxyContin ER 15 mg every 4 hours delivers substantially more oxycodone per day and is therefore the stronger regimen

Dosing Frequency Error

OxyContin ER 12-hour formulation should never be dosed every 4 hours—this represents a critical prescribing error that triples the intended daily dose. 1, 2

  • OxyContin ER is designed for administration every 12 hours, not every 4 hours 2, 3
  • Dosing OxyContin ER every 4 hours would result in 6 doses per day (90 mg total daily dose) instead of the intended 2 doses per day (30 mg total daily dose) 2
  • Extended-release formulations have peak plasma concentrations delayed to 2-6 hours and are specifically engineered for 12-hour duration of action 4, 3

Total Daily Dose Comparison

If OxyContin ER 15 mg is incorrectly dosed every 4 hours (as stated):

  • Total daily oxycodone: 90 mg (15 mg × 6 doses)
  • MME equivalent: 135 MME/day (using 1.5 conversion factor) 1

If oxycodone HCl IR 10 mg is correctly dosed every 4 hours:

  • Total daily oxycodone: 60 mg (10 mg × 6 doses)
  • MME equivalent: 90 MME/day (using 1.5 conversion factor) 1

The OxyContin ER regimen as written delivers 50% more total daily opioid than the immediate-release oxycodone regimen. 1

Relative Potency Considerations

  • Oxycodone has an equianalgesic conversion factor of 1.5 relative to morphine (meaning oxycodone is 1.5 times stronger than morphine milligram-per-milligram) 1
  • Both formulations contain the same active ingredient (oxycodone), so the only difference is total daily dose and release kinetics 2, 5
  • Immediate-release oxycodone reaches peak plasma concentrations within 1 hour with 3-4 hour duration 2
  • Extended-release oxycodone has 60-87% oral bioavailability and reaches peak concentrations in 2-4 hours with 12-hour duration 2, 3

Critical Safety Concerns

Dosing OxyContin ER every 4 hours places the patient at 135 MME/day, which exceeds the CDC threshold of 90 MME/day associated with significantly increased overdose risk. 1

  • The CDC guideline emphasizes careful reassessment before increasing dosages to ≥50 MME/day and progressive increases in risk as dosage increases 1
  • Dosages ≥90 MME/day have limited evidence of benefit and substantially elevated mortality risk 1
  • Breaking, crushing, or chewing OxyContin ER tablets (or taking them more frequently than intended) can result in rapid release and absorption of a potentially fatal dose 2

Correct Prescribing Practice

The appropriate comparison should be:

  • Oxycodone IR 10 mg every 4 hours (60 mg/day = 90 MME/day)
  • OxyContin ER 15 mg every 12 hours (30 mg/day = 45 MME/day)

Under correct dosing, the immediate-release regimen would be twice as strong as the extended-release regimen. 1, 2

Common Pitfall

  • Never increase dosing frequency of extended-release formulations—instead, increase the dose amount if pain control is inadequate 1, 6
  • Modified-release formulations are designed for 12-hour intervals; more frequent dosing defeats the purpose of the extended-release mechanism and creates dangerous overdose risk 1, 4
  • For breakthrough pain on a 12-hourly ER regimen, provide immediate-release oxycodone as rescue medication at 10-20% of the total daily dose, available every 1-2 hours as needed 1, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oxycodone: a pharmacological and clinical review.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2007

Guideline

Morphine Pharmacokinetics and Elimination

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Safe Dose Escalation of Long-Acting Morphine for Uncontrolled Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.